查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1715685

尿道结石管理设备市场（按设备类型、治疗类型、设备材料、应用和最终用户划分）—2025 年至 2030 年全球预测

Urolithiasis Management Devices Market by Device Type, Treatment Type, Device Material, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2024 年尿道结石管理设备市场规模将达到 4.9076 亿美元，到 2025 年将达到 5.2703 亿美元，到 2030 年将达到 7.673 亿美元，复合年增长率为 7.73%。

主要市场统计数据
基准年2024年 4.9076亿美元
预计2025年 5.2703亿美元
预测年份 2030 7.673亿美元
复合年增长率（%） 7.73%

目前，尿道结石管理设备领域正处于技术快速创新和转型的时期。在当今的医疗保健环境中，技术进步促进了设备的开发，使得治疗肾结石、输尿管结石和膀胱结石的设备更加精确、高效和安全。这个充满活力的领域将复杂的医学工程与不断发展的临床实践相结合，以解决最常见的泌尿道疾病之一。

包括临床医生、生物医学工程师和医院管理人员在内的相关人员一直在寻找不仅可以改善病患治疗效果而且可以减少手术併发症的解决方案。先进影像技术、微创介入技术和改进的人体工学设备的整合极大地改变了结石管理的实践。这种演变代表着一种渐进的转变，其中传统方法正在被旨在透过内视镜和非侵入性方法治疗尿道结石的最先进的设备所补充甚至取代。

在这种环境下，专家的洞察力和基于证据的数据指南决策并推动研发投资。随着技术创新不断颠覆传统方法，临床效果与技术进步之间的相互作用将决定未来策略的蓝图。利用这些改进来增强临床工作流程和患者照护的机会比以往任何时候都更加突出，这表明整个市场前景光明。

推动尿道结石市场变革

近年来，我们看到了重新定义尿道结石管理设备市场的变革性变化。技术创新的步伐正在引领设备不仅更有效率，而且更加安全、易于使用。技术创新带来了影像的改善、导航能力的增强以及手术过程中的即时回馈机制。这种演变的部分原因是人们对微创手术的需求不断增加、患者舒适度提高和恢復时间缩短。

监管政策也在不断发展，以促进创新医疗设备更快进入市场，同时仍优先考虑病患安全。临床医生和技术专家之间的合作努力正在引领针对尿道结石治疗细节的设备的开发。医疗保健提供者现在越来越多地采用与现有医院基础设施无缝整合的技术，并透过自动化和数位监控简化复杂的程序。

此外，市场正在逐渐从传统的手术方法转向结合基于人工智慧的诊断和程序指导的数位技术。随着业界认识到这些新设备尚未开发的潜力，研发投资持续稳定成长。这种不断变化的格局由不断发展的生态系统所支撑，该生态系统将创新与可操作的、基于证据的临床结果相结合。透过临床医生和医疗设备製造商之间的协同效应，改善患者治疗效果和提高成本效率正在迅速成为现实。

深入市场区隔：深入了解设备、治疗、材料、应用和最终用户

对尿道结石管理设备市场的全面分析揭示了一种复杂的细分策略，可以捕捉市场格局的多样性。根据设备类型进行细分，将市场分为导管导引线、碎石机、支架、输尿管镜等部分，每个部分在治疗通讯协定中都发挥独特的作用。从治疗类型的角度来看市场，很明显体外震波碎石术、腔内碎石术和经皮肾镜碎石术是首选的治疗方法，每种治疗方法在侵入性和恢復时间方面都具有明显的优势。

透过根据设备材料进行细分，将市场分为基于金属的设备和基于聚合物的设备，进一步丰富了分析。这种分类有助于了解影响治疗结果的性能、耐用性和患者特定考虑因素方面的差异。此外，透过关注基于应用的分类，市场研究涵盖了与膀胱结石、肾结石和输尿管结石相关的病理，从而提供了针对治疗需求和外科专业的客製化视图。

市场区隔的另一个方面着重于最终用户，包括门诊手术中心、医院和专科诊所。这种细分策略观点可以更深入地了解市场需求、收购趋势以及每个最终用户类别的独特要求。这些不同部分的相互作用有助于全面了解当前的市场动态，确保从技术创新到临床应用的所有方面都纳入整体评估中。对于寻求在竞争激烈且快速发展的环境中製定策略的相关人员来说，这种细緻的框架至关重要。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 尿道结石发生率不断上升，老龄人口不断增加
      • 非侵入性手术的趋势和对微创技术的认识日益增强
      • 医院领域越来越多地采用创新技术
    • 限制因素
      • 尿道结石治疗设备有限且成本高昂
    • 机会
      • 可携式、用户友好的尿道结石管理设备的开发
      • 有效治疗尿道结石的微创设备技术进步
    • 任务
      • 担心治疗可能产生的副作用
  • 市场区隔分析
    • 设备类型：输尿管镜因其在取石方面卓越的视觉和机械性能而越来越受到青睐
    • 应用：拓展尿道结石管理设备在膀胱结石管理的应用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章尿道结石管理设备市场（依设备类型）

  • 导管导引线
  • 碎石机
  • 支架
  • 输尿管镜

第七章尿道结石管理设备市场（依治疗类型）

  • 体外震波碎石术
  • 体内碎石术
  • 经皮肾镜取石术

第八章尿道结石管理设备市场（依设备材料）

  • 金属基元件
  • 基于聚合物的设备

第九章尿道结石管理设备市场（依应用）

  • 膀胱结石
  • 肾结石
  • 输尿管结石

第 10 章尿道结石管理设备市场（依最终用户）

  • 门诊手术中心
  • 医院
  • 专科诊所

11. 美洲尿道结石管理设备市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

12. 亚太地区尿道结石管理设备市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

13. 欧洲、中东和非洲尿道结石管理设备市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十四章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • Advanced MedTech Holdings
  • AKSM, Ltd.
  • Avvio Medical, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Calyxo Inc.
  • Coloplast A/S
  • Cook Group Incorporated
  • DirexGroup
  • Dornier MedTech GmbH
  • Dyne Medical Group Inc.
  • EMS Electro Medical Systems SA
  • EDAP TMS SA
  • Elmed Lithotripsy Systems
  • EndoTheia, Inc.
  • Karl Storz GmbH & Co. KG
  • Nissha Medical Technologies
  • Olympus Corporation
  • Quanta System SpA
  • Richard Wolf GmbH
  • Siemens Healthineers
  • SonoMotion
  • Teleflex Incorporated
Product Code: MRR-ED54C46E9009

The Urolithiasis Management Devices Market was valued at USD 490.76 million in 2024 and is projected to grow to USD 527.03 million in 2025, with a CAGR of 7.73%, reaching USD 767.30 million by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 490.76 million
Estimated Year [2025] USD 527.03 million
Forecast Year [2030] USD 767.30 million
CAGR (%) 7.73%

The current landscape of urolithiasis management devices is witnessing an era of rapid innovation and transformative change. In today's healthcare environment, technological advances have led to the development of devices that offer enhanced precision, efficiency, and safety for the treatment of kidney stones, ureteral stones, and bladder stones. This dynamic field blends intricate medical engineering with evolving clinical practices to address one of the most prevalent urinary tract disorders.

Stakeholders including clinicians, biomedical engineers, and hospital administrators are consistently on the lookout for solutions that not only improve patient outcomes but also reduce procedural complications. The integration of advanced imaging, minimally invasive intervention techniques, and improved device ergonomics has dramatically reshaped practices in stone management. This evolution signifies a progressive shift where traditional methods are being supplemented or even replaced by state-of-the-art devices designed to manage urolithiasis through both endoscopic and non-invasive approaches.

In this environment, expert insights and evidence-based data guide decision-making and foster investments in research and development. As innovation continues to disrupt conventional methods, the interplay between clinical efficacy and technological advancements defines the roadmap for future strategies. The opportunity to leverage these improvements for enhanced clinical workflows and patient care is more pronounced than ever, indicating a promising outlook for the market overall.

Transformative Shifts Driving the Urolithiasis Market

Recent years have been marked by transformative shifts that are redefining the urolithiasis management device market. The pace of technological innovation has ushered in devices that are not only more efficient but also safer and easier to use. Innovations have led to improvements in imaging techniques, enhanced navigation capabilities, and real-time feedback mechanisms during surgeries. This evolution has partly been driven by a growing demand for minimally invasive procedures, improved patient comfort, and reduced recovery times.

Regulatory policies have also evolved, facilitating faster market entry for innovative medical devices while ensuring patient safety remains paramount. Collaborative efforts between clinical practitioners and technical experts have fostered the creation of devices that are increasingly tailored to the nuances of urolithiasis treatment. Healthcare providers are now more inclined to adopt technology that integrates seamlessly with existing hospital infrastructure and simplifies complex procedures through automation and digital oversight.

Furthermore, the market is witnessing a gradual shift from traditional surgical methods to digitally-enhanced techniques that incorporate AI-driven diagnostics and procedural guidance. Investment in research and development continues to flow steadily as industries recognize the untapped potential of these novel devices. The transformation in the landscape is underpinned by an evolving ecosystem that blends innovation with practical, evidence-based clinical outcomes. As clinicians and medical device manufacturers work synergistically, the promise of improved therapeutic outcomes combined with cost-efficiency is rapidly becoming a reality.

Deep Dive: Market Segmentation Insights into Device, Treatment, Material, Application, and End Users

A comprehensive analysis of the urolithiasis management device market reveals an intricate segmentation strategy that captures the diversity of the market landscape. The segmentation based on device type dissects the market into segments that include guidewires, lithotripters, stents, and ureteroscopes, each playing a unique role in the treatment protocol. When the market is examined through the lens of treatment type, it is clear that extracorporeal shock wave lithotripsy, intracorporeal lithotripsy, and percutaneous nephrolithotomy are at the forefront of procedural choices, each offering distinct advantages regarding invasiveness and recovery time.

The analysis is further enriched by segmentation based on device material, categorizing the market into metal-based devices and polymer-based devices. This classification helps in understanding performance differences, durability, and patient-specific considerations that underline treatment efficacy. Moreover, by looking at the application-based categorization, the market study addresses conditions pertaining to bladder stones, kidney stones, and ureteral stones, thereby offering a tailored view of therapeutic needs and operational specialties.

Another dimension of market segmentation focuses on the end user, encompassing ambulatory surgical centers, hospitals, and specialty clinics. This perspective of the segmentation strategy allows for a better understanding of market demand, acquisition trends, and the unique requirements of each end user category. The interplay of these diverse segments contributes to a holistic view of current market dynamics, ensuring that every aspect from technological innovation to clinical application is captured in the overall assessment. This nuanced framework is essential for stakeholders looking to strategize in a competitive and rapidly evolving landscape.

Based on Device Type, market is studied across Guidewires, Lithotripters, Stents, and Ureteroscopes.

Based on Treatment Type, market is studied across Extracorporeal Shock Wave Lithotripsy, Intracorporeal Lithotripsy, and Percutaneous Nephrolithotomy.

Based on Device Material, market is studied across Metal-Based Devices and Polymer-Based Devices.

Based on Application, market is studied across Bladder Stones, Kidney Stones, and Ureteral Stones.

Based on End User, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.

Regional Dynamics Shaping Global and Local Markets

The global distribution of urolithiasis management devices is significantly influenced by varying regional characteristics and healthcare infrastructure maturity. In the Americas, market growth is primarily driven by well-established healthcare systems and an increasing adoption rate of minimally invasive procedures. Regulatory frameworks in the region encourage early adoption of innovative technologies, thereby setting the stage for sustained market growth.

Across Europe, the Middle East, and Africa, there is a noticeable trend towards gradual modernization of healthcare delivery systems. Advanced medical centers, combined with the growing emphasis on patient safety and device efficacy, have markedly contributed to regional market dynamics. Clinical adoption in these regions is enhanced by targeted initiatives aimed at improving patient outcomes and reducing post-procedural complications. The diversity of healthcare systems within these areas presents both challenges and opportunities, requiring tailored strategic responses from manufacturers and service providers.

Meanwhile, the Asia-Pacific region is emerging as one of the fastest-growing markets for urolithiasis management devices. Rising healthcare expenditures, expanding infrastructure, and a surge in medical tourism are key factors driving market evolution. The blend of traditional practices with modern medical innovation creates a fertile ground for advanced device adoption. Furthermore, this region has seen significant improvements in access to specialized healthcare services, facilitating the integration of new technological advancements into current clinical practices. Together, these regional insights underscore a global scenario where local demand, regulatory policies, and infrastructure readiness collectively shape market trajectories.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Leading Innovators in the Urolithiasis Device Sphere

The competitive landscape in the urolithiasis management device market is characterized by contributions from several leading innovators who have significantly influenced both technological advancement and market penetration. Industry pioneers such as Advanced MedTech Holdings have consistently set benchmarks through extensive research and development initiatives. Similarly, companies like AKSM, Ltd. and Avvio Medical, Inc. are making remarkable strides in designing devices that cater to highly specialized clinical requirements, while Becton, Dickinson and Company alongside Boston Scientific Corporation are leveraging their global footprint to drive widespread acceptance of novel treatment methodologies.

Other key players including Calyxo Inc. and Coloplast A/S have focused on enhancing device ergonomics and integrating user-centric functionalities to ensure seamless operation during surgical procedures. Cook Group Incorporated and DirexGroup bring a strategic blend of technological innovation and robust distribution networks that position them as reliable partners in the market. Additionally, Dornier MedTech GmbH, Dyne Medical Group Inc., and E.M.S. Electro Medical Systems S.A. have been pivotal in pushing the boundaries of device precision and patient safety.

EDAP TMS SA, Elmed Lithotripsy Systems, EndoTheia, Inc., and Karl Storz GmbH & Co. KG are also at the forefront of transformative developments in this sector. The contributions from innovators such as Nissha Medical Technologies, Olympus Corporation, Quanta System S.p.A., Richard Wolf GmbH, Siemens Healthineers, SonoMotion, and Teleflex Incorporated illustrate the market's evolving nature. Each of these companies has embraced a forward-thinking approach that not only enhances device functionality but also aligns with the latest trends in patient-centered care. Their collective efforts have led to significant improvements in device reliability, user experience, and clinical outcomes, positioning the industry for long-term growth.

The report delves into recent significant developments in the Urolithiasis Management Devices Market, highlighting leading vendors and their innovative profiles. These include Advanced MedTech Holdings, AKSM, Ltd., Avvio Medical, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Calyxo Inc., Coloplast A/S, Cook Group Incorporated, DirexGroup, Dornier MedTech GmbH, Dyne Medical Group Inc., E.M.S. Electro Medical Systems S.A., EDAP TMS SA, Elmed Lithotripsy Systems, EndoTheia, Inc., Karl Storz GmbH & Co. KG, Nissha Medical Technologies, Olympus Corporation, Quanta System S.p.A., Richard Wolf GmbH, Siemens Healthineers, SonoMotion, and Teleflex Incorporated. Guiding Strategic Recommendations for Market Excellence

Industry stakeholders need to adopt a multi-faceted strategy to maintain a competitive edge in the evolving market of urolithiasis management devices. One of the first actionable recommendations is to ensure ongoing investment in research and development, particularly in areas that enhance device precision and improve patient safety. Stakeholders should collaborate closely with clinical research bodies to ensure that new products not only meet regulatory standards but also align with the evolving needs of the healthcare market.

Another key recommendation is to strengthen partnerships across the value chain, ranging from raw material suppliers to healthcare practitioners who deploy these devices in clinical settings. Effective collaboration can facilitate the integration of digital technologies and analytics, allowing companies to streamline operations and develop devices that deliver both cost efficiency and enhanced procedural outcomes. It is also advisable for manufacturers to remain agile in response to regional variations in market dynamics; tailoring strategies for different geographies by understanding local regulatory environments, healthcare priorities, and patient demographics can yield significant competitive advantages.

Moreover, companies should focus on training and support programs that empower clinical teams to fully leverage the benefits of advanced urolithiasis management technology. Emphasizing continuous education, workshops, and real-world case demonstrations can boost confidence among users and accelerate the adoption curve. Strategic investments in digital marketing and thought leadership are also critical in establishing a strong brand presence and influencing decision-makers in the healthcare sector. By adopting these recommendations, industry leaders can not only secure their market position but also drive transformative changes that resonate across clinical practices worldwide.

Concluding Reflections on Market Trends and Future Prospects

In conclusion, the current market for urolithiasis management devices is set on a promising path, driven by significant technological advancements and an increasing emphasis on minimally invasive procedures. The strategic integration of innovations, ranging from advanced imaging to digital analytics, has fundamentally altered the approach to managing urolithiasis. As stakeholders navigate this dynamic environment, a deep understanding of market segmentation, regional dynamics, and competitive forces remains critical.

The insights gathered from both qualitative and quantitative analyses suggest that market players must continue to invest in product development and embrace collaborative partnerships to meet the rising expectations of healthcare providers. The future of urolithiasis management is not solely reliant on isolated technological innovations but also on the seamless integration of these advancements within existing clinical infrastructures. As global healthcare demands evolve, businesses that maintain a patient-centric approach, focus on reliability, and adapt swiftly to market changes are likely to thrive.

The continuous evolution in this industry will undoubtedly usher in further developments that may set new standards for efficiency and efficacy in patient care. As medical professionals, researchers, and device manufacturers build on the current momentum, the overall impact on patient outcomes could be transformative. Ultimately, the convergence of innovation, strategic investments, and a comprehensive understanding of market dynamics will drive the future success and sustainability of the urolithiasis management device sector.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of urinary stones and increasing elderly population
      • 5.1.1.2. Rising proclivity for non-invasive surgeries and awareness of minimally invasive techniques
      • 5.1.1.3. Increasing adoption of innovative technologies in the hospital sector
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability and high cost of urolithiasis devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of portable and user-friendly urolithiasis management devices
      • 5.1.3.2. Technological advancements in minimally invasive devices for effective urolithiasis treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns over probable side effects of the treatment
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Device Type: Rising preference for ureteroscopes owing to visual and mechanical excellence in stone extraction
    • 5.2.2. Application: Expanding application of urolithiasis management devices for bladder stone management
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Urolithiasis Management Devices Market, by Device Type

  • 6.1. Introduction
  • 6.2. Guidewires
  • 6.3. Lithotripters
  • 6.4. Stents
  • 6.5. Ureteroscopes

7. Urolithiasis Management Devices Market, by Treatment Type

  • 7.1. Introduction
  • 7.2. Extracorporeal Shock Wave Lithotripsy
  • 7.3. Intracorporeal Lithotripsy
  • 7.4. Percutaneous Nephrolithotomy

8. Urolithiasis Management Devices Market, by Device Material

  • 8.1. Introduction
  • 8.2. Metal-Based Devices
  • 8.3. Polymer-Based Devices

9. Urolithiasis Management Devices Market, by Application

  • 9.1. Introduction
  • 9.2. Bladder Stones
  • 9.3. Kidney Stones
  • 9.4. Ureteral Stones

10. Urolithiasis Management Devices Market, by End User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Hospitals
  • 10.4. Specialty Clinics

11. Americas Urolithiasis Management Devices Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Urolithiasis Management Devices Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Urolithiasis Management Devices Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Nissha and Endotheia unveil FlexStone Basket, enhancing kidney stone removal through innovation and collaboration
    • 14.3.2. FDA de novo clearance granted to Stone Clear, a non-invasive device for managing post-lithotripsy kidney stones and reducing relapse risk
    • 14.3.3. Olympus enhances urolithiasis management with FDA-cleared RenaFlex single-use flexible ureteroscope
    • 14.3.4. Calyxo receives FDA approval for redesign of device that collects kidney stone fragments
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advanced MedTech Holdings
  • 2. AKSM, Ltd.
  • 3. Avvio Medical, Inc.
  • 4. Becton, Dickinson and Company
  • 5. Boston Scientific Corporation
  • 6. Calyxo Inc.
  • 7. Coloplast A/S
  • 8. Cook Group Incorporated
  • 9. DirexGroup
  • 10. Dornier MedTech GmbH
  • 11. Dyne Medical Group Inc.
  • 12. E.M.S. Electro Medical Systems S.A.
  • 13. EDAP TMS SA
  • 14. Elmed Lithotripsy Systems
  • 15. EndoTheia, Inc.
  • 16. Karl Storz GmbH & Co. KG
  • 17. Nissha Medical Technologies
  • 18. Olympus Corporation
  • 19. Quanta System S.p.A.
  • 20. Richard Wolf GmbH
  • 21. Siemens Healthineers
  • 22. SonoMotion
  • 23. Teleflex Incorporated

LIST OF FIGURES

  • FIGURE 1. UROLITHIASIS MANAGEMENT DEVICES MARKET MULTI-CURRENCY
  • FIGURE 2. UROLITHIASIS MANAGEMENT DEVICES MARKET MULTI-LANGUAGE
  • FIGURE 3. UROLITHIASIS MANAGEMENT DEVICES MARKET RESEARCH PROCESS
  • FIGURE 4. UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. UROLITHIASIS MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. UROLITHIASIS MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. UROLITHIASIS MANAGEMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. UROLITHIASIS MANAGEMENT DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY LITHOTRIPTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETEROSCOPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY INTRACORPOREAL LITHOTRIPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY PERCUTANEOUS NEPHROLITHOTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY METAL-BASED DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY POLYMER-BASED DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY BLADDER STONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY KIDNEY STONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY URETERAL STONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY DEVICE MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 236. UROLITHIASIS MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 237. UROLITHIASIS MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2024